Study Protocol for the Effects of Formula Diet with Dapagliflozin on Metabolic Improvement and Body Composition in Type 2 Diabetes Mellitus
This study is ongoing and scheduled to complete in June 2019. The findings of this study will be disseminated through peer-reviewed publications and conference presentations.Trial RegistrationUniversity Hospital Medical Information Network (UMIN) 000024580.FundingThis study was carried out under contract with the specified nonprofit corporation Hokkaido Institute of Health Sciences, based on a grant from AstraZeneca Co., Ltd. and Ono Pharmaceutical Co., Ltd. for an investigator-initiated clinical trial. The authors funded the journals article processing charges.
Source: Diabetes Therapy - Category: Endocrinology Source Type: research
More News: AstraZeneca | Balanced Diets | Carbohydrates | Clinical Trials | Conferences | Contracts | Dapagliflozin | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Diets | Eating Disorders & Weight Management | Endocrinology | Forxiga | Grants | High Fat | Hospitals | Insulin | Minerals | Nutrition | Obesity | SGLT2 Inhibitors | Study | Vitamins | Weight Loss